Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Saltigo is a German contract development and manufacturing organization focused on custom manufacturing and process development for fine chemicals, including pharmaceutical active ingredients and intermediates. Operating as a wholly owned subsidiary of LANXESS since 2006, the company supports customer projects from early-stage process development and scale-up through commercial multi-ton production. Saltigo primarily serves the pharmaceutical, crop protection, and specialty chemicals markets from production sites in Leverkusen and Dormagen, Germany. Its offering includes custom synthesis, pilot operations, industrial scale-up, selected fine chemical intermediates, and the insect repellent active ingredient Saltidin (icaridin). For biotech and pharma analysts, Saltigo is best understood as an established small-molecule CDMO and specialty chemical manufacturer rather than a therapeutics developer.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Saltigo.